|
|
Article: ESTORRA(TM) Six-Month Study Data Receives Rapid Peer Review and Publication in the Journal SLEEP.
- Article from:
- PR Newswire
- Article date:
- October 21, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sepracor Inc. today announced that data from its six-month, Phase III, randomized, double-blind, placebo-controlled safety and efficacy study of ESTORRA(TM) brand eszopiclone for the treatment of chronic insomnia was published in the journal SLEEP, the official publication of the Associated Professional Sleep Societies. This manuscript was deemed by the publishers of SLEEP to be of sufficient scientific importance and interest to the clinical and research community to warrant rapid peer review and publication.
"The results of this study demonstrate that nightly use of ESTORRA provided statistically significant improvements compared with placebo in patient ...